The trifunctional antibody catumaxomab amplifies and shapes tumor-specific immunity when applied to gastric cancer patients in the adjuvant setting

Transient lymphocyte decrease due to adhesion and migration following catumaxomab (anti-EpCAM x anti-CD3) treatment in vivo

(2012) Kirsten Dettmar et al.   Clinical & Translational Oncology

Immunomonitoring Results of a Phase II/III Study of Malignant Ascites Patients Treated with the Trifunctional Antibody Catumaxomab (Anti-EpCAM x Anti-CD3)

(2011) M. Jager et al.   CANCER RESEARCH

Chemotherapy Induces Intratumoral Expression of Chemokines in Cutaneous Melanoma, Favoring T-cell Infiltration and Tumor Control

(2011) M. Hong et al.   CANCER RESEARCH

Sirolimus- vs. paclitaxel-eluting stent to coronary intervention in dialysis patients

(2011) Daisuke Kamoi et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Retrospective Analysis of Adjuvant Intraperitoneal Chemotherapy Effect Prognosis of Resectable Gastric Cancer

(2011) Chunmei Shi et al.   ONCOLOGY

Multimodality treatment for localized gastro-oesophageal cancer

(2010) A. F. C. Okines et al.   ANNALS OF ONCOLOGY

Efficacy of catumaxomab in tumor spheroid killing is mediated by its trifunctional mode of action

(2010) Franziska Hirschhaeuser et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Repeated PR1 and WT1 peptide vaccination in Montanide-adjuvant fails to induce sustained high-avidity, epitope-specific CD8+ T cells in myeloid malignancies

(2010) K. Rezvani et al.   HAEMATOLOGICA

The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial

(2010) Markus M. Heiss et al.   INTERNATIONAL JOURNAL OF CANCER

Increase of Circulating CD4+CD25highFoxp3+ Regulatory T Cells in Patients With Metastatic Renal Cell Carcinoma During Treatment With Dendritic Cell Vaccination and Low-Dose Interleukin-2

(2010) Annika Berntsen et al.   JOURNAL OF IMMUNOTHERAPY

Pro-inflammatory chemokine-chemokine receptor interactions within the Ewing sarcoma microenvironment determine CD8+ T-lymphocyte infiltration and affect tumour progression

(2010) Dagmar Berghuis et al.   JOURNAL OF PATHOLOGY

EpCAM, a human tumor-associated antigen promotes Th2 development and tumor immune evasion

(2009) A. Ziegler et al.   BLOOD

Prognostic implications of type and density of tumour-infiltrating lymphocytes in gastric cancer

(2008) H E Lee et al.   BRITISH JOURNAL OF CANCER